DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice
- PMID: 17950578
- DOI: 10.1016/j.bbadis.2007.08.004
DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice
Abstract
Myotonic dystrophy (DM1) is a dominant autosomal multisystemic disorder caused by the expansion of an unstable CTG trinucleotide repeat in the 3' untranslated region of the DMPK gene. Nuclear accumulation of the enlarged CUG-containing DMPK transcripts has a deleterious effect on the regulation of alternative splicing of some RNAs and has a central role in causing the symptoms of DM1. In particular, Insulin Receptor (IR) mRNA splicing defects have been observed in the muscle of DM1 patients. In this study, we have investigated IR splicing in insulin-responsive tissues (i.e. skeletal muscles, adipose tissue, liver) and pancreas and we have studied glucose metabolism in mice carrying the human genomic DM1 region with expanded (>350 CTG) or normal (20 CTG) repeats and in wild-type mice. Mice carrying DM1 expansions displayed a tissue- and age-dependent abnormal regulation of IR mRNA splicing in all the tissues that we investigated. Furthermore, these mice showed a basal hyperglycemia and glucose intolerance which disappeared with age. Our findings show that deregulation of IR splicing due to the DM1 mutation can occur in different mouse tissues, suggesting that CTG repeat expansions might also result in IR misplicing not only in muscles but also in other tissues in DM1 patients.
Similar articles
-
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.PLoS Genet. 2012;8(11):e1003043. doi: 10.1371/journal.pgen.1003043. Epub 2012 Nov 29. PLoS Genet. 2012. PMID: 23209425 Free PMC article.
-
Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.Hum Mol Genet. 2001 Nov 1;10(23):2717-26. doi: 10.1093/hmg/10.23.2717. Hum Mol Genet. 2001. PMID: 11726559
-
Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.PLoS One. 2015 Sep 4;10(9):e0137620. doi: 10.1371/journal.pone.0137620. eCollection 2015. PLoS One. 2015. PMID: 26339785 Free PMC article.
-
Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.Curr Neurol Neurosci Rep. 2002 Sep;2(5):465-70. doi: 10.1007/s11910-002-0074-6. Curr Neurol Neurosci Rep. 2002. PMID: 12169228 Review.
-
Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.Clin Genet. 2017 Oct;92(4):355-364. doi: 10.1111/cge.12954. Epub 2017 Feb 22. Clin Genet. 2017. PMID: 27991661 Review.
Cited by
-
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.PLoS Genet. 2012;8(11):e1003043. doi: 10.1371/journal.pgen.1003043. Epub 2012 Nov 29. PLoS Genet. 2012. PMID: 23209425 Free PMC article.
-
Transcriptionally Repressive Chromatin Remodelling and CpG Methylation in the Presence of Expanded CTG-Repeats at the DM1 Locus.J Nucleic Acids. 2013;2013:567435. doi: 10.1155/2013/567435. Epub 2013 Dec 23. J Nucleic Acids. 2013. PMID: 24455202 Free PMC article.
-
DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death.Molecules. 2019 Sep 1;24(17):3175. doi: 10.3390/molecules24173175. Molecules. 2019. PMID: 31480541 Free PMC article.
-
Structure of dystrophia myotonica protein kinase.Protein Sci. 2009 Apr;18(4):782-91. doi: 10.1002/pro.82. Protein Sci. 2009. PMID: 19309729 Free PMC article.
-
Tissue- and age-specific DNA replication patterns at the CTG/CAG-expanded human myotonic dystrophy type 1 locus.Nat Struct Mol Biol. 2010 Sep;17(9):1079-87. doi: 10.1038/nsmb.1876. Epub 2010 Aug 15. Nat Struct Mol Biol. 2010. PMID: 20711191
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
